// App-Quantinova.ai

2717 : Reintroduction of DAXX suppresses alternative lengthening of telomeres in osteosarcoma

Researchers

Presenter

  • Kathryn E. Driest

Principal Investigators

  • Joshua J. Waterfall

  • Robert L. Walker

  • Marbin A. Pineda

  • Ogan Abaan

  • Yuelin J. Zhu

  • Yonghong Wang

  • Corbin D. Ester

  • Sean R. Davis

  • Sven Bilke

  • Paul S. Meltzer

Medical Centers

  • NCI-CCR, Bethesda, MD.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Osteosarcoma

  • Solid malignancies

  • ATRX syndrome

Biomarkers

  • Alpha thalassemia mental retardation X-linked protein

  • Promyelocytic Leukemia

  • Death Domain Associated Protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved